A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults

NCT06967181 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Mumps

Interventions

BIOLOGICAL: CVM150
BIOLOGICAL: CVM26
OTHER: Placebo

Sponsor

CyanVac LLC